23,802
Participants
Start Date
June 28, 2007
Primary Completion Date
August 31, 2010
Study Completion Date
July 28, 2011
Pneumococcal conjugate vaccine GSK1024850A
Intramuscular injection, 4 doses
Havrix
Intramuscular injection, 2 doses in Synflorix group and 3 doses in Control group
Engerix-B
Intramuscular injection, 3 doses
Infanrix hexa
Intramuscular injection,3 doses
GSK Biologicals' DTPa-IPV/Hib vaccine
Intramuscular injection, 1 dose in Synflorix group and 4 doses in Control group
GSK Investigational Site, Fernández
GSK Investigational Site, Santiago del Estero
GSK Investigational Site, La Banda
GSK Investigational Site, La Banda
GSK Investigational Site, Santiago del Estero
GSK Investigational Site, Córdoba
GSK Investigational Site, San Juan
GSK Investigational Site, San Juan
GSK Investigational Site, Mendoza
GSK Investigational Site, Godoy Cruz
GSK Investigational Site, Las Heras
GSK Investigational Site, Luján de Cuyo
GSK Investigational Site, Villa Nueva
GSK Investigational Site, Villanueva
GSK Investigational Site, Albardón
GSK Investigational Site, Caucete
GSK Investigational Site, Maipú
GSK Investigational Site, San Juan
GSK Investigational Site, San Martín
GSK Investigational Site, Santiago del Estero
GSK Investigational Site, Santiago de Cali
GSK Investigational Site, Panama City
Lead Sponsor
GlaxoSmithKline
INDUSTRY